| Dr Paula L Timmons, PHD | |
|
4101 S 4th St, Leavenworth, KS 66048-5014 | |
| (913) 682-2000 | |
| (913) 758-4273 |
| Full Name | Dr Paula L Timmons |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Counseling |
| Location | 4101 S 4th St, Leavenworth, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023061835 | NPI | - | NPPES |
| 060736 | Other | KS | BLUE CROSS BLUE SHIELD KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 0897 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paula L Timmons, PHD 1021 Biltmore Dr, Lawrence, KS 66049-4736 Ph: (785) 691-6067 | Dr Paula L Timmons, PHD 4101 S 4th St, Leavenworth, KS 66048-5014 Ph: (913) 682-2000 |
News Archive
Glancy Binkow & Goldberg LLP has been appointed as Co-Lead Counsel in the securities class action against Skilled Healthcare Group, Inc., certain of the Company's executive officers, and certain underwriters of the Company's May 2007 initial public offering ("IPO"), currently pending in the United States District Court for the Central District of California - Shepardson v. Skilled Healthcare Group, Inc., et al., No. CV 09-5416-DOC (RZx).
The Washington Post: "Thousands of people rallied loudly for passage of health-care legislation in Northern Virginia Friday as President Obama tried one final time to demonstrate public support for the health-care bill that is moving toward a Sunday afternoon vote in Congress.
Preliminary study data show that axitinib may be an effective first-line treatment for metastatic renal cell carcinoma, particularly in patients with high therapeutic drug exposure and a rise in blood pressure during the first 2 weeks of treatment, researchers report.
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced it has dosed the first patient with recent onset of non-arteritic anterior ischemic optic neuropathy (NAION) in its ongoing Phase I study of QPI-1007, the Company's proprietary synthetic siRNA drug candidate for ocular neuroprotection.
› Verified 2 days ago
Dr. Kylie L Dowell, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 | |
Deborah Lynn Weidinger, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3515 S 4th Street, Professional Association, Leavenworth, KS 66048 Phone: 913-651-8415 Fax: 913-772-8580 | |
Dr. Amber D. Guzman, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-946-1561 | |
Jim Sharpnack, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Limit St, Leavenworth, KS 66048 Phone: 913-682-5118 Fax: 913-682-4664 | |
Dakota Mcnamara Thornblade, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Limit St, Leavenworth, KS 66048 Phone: 913-682-4664 | |
Dr. Erin Elisabeth Mills, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |